World Health Organization (WHO). Hepatitis B: Key facts. http://www.who.int/news-room/fact-sheets/detail/hepatitis-b
World Health Organization (WHO). Guidelines on hepatitis B and C testing. http://www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/.
Centers for Disease Control and Prevention. Viral hepatitis B. https://www.cdc.gov/hepatitis/hbv/index.htm
Kao WY, Su CW, Tan EC, Lee PC, Chen PH, Tang JH, et al. Proton pump inhibitors and risk of hepatocellular carcinoma in patients with chronic hepatitis B or C. Hepatology. 2018. https://doi.org/10.1002/hep.30247.
Choi J, Kim GA, Han S, Lee W, Chun S, Lim YS. Longitudinal assessment of three serum biomarkers to detect very early stage hepatocellular carcinoma. Hepatology. 2018. https://doi.org/10.1002/hep.30233.
Lisa PW, Vrushak D, Nikolaos P. Hepatocellular carcinoma: A comprehensive review. World J Hepatol. 2015;7(26):2648–63.
World Health Organization (WHO). Global hepatitis report 2017. http://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf;jsessionid=699D49FD849542F6768BBDEC9279E810?sequence=18.
Xu C, Chen T. Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission. Lancet Gastroenterol Hepatol. 2018;3(9):598–9.
Gao X, Wang X, Zhu B. The distribution of Chinese minority populations and its change based on the study of the Hu Huanyong line. Int J Anthropol Ethnol. 2017;1(2). https://doi.org/10.1186/s41257-017-0004-9.
Princess Maha Chakri Siridhorn Anthropology center. Hill tribe. 2018. http://www.sac.or.th/main/index.php
Lukas H. Southeast Asian hill tribes and the opium trade – The historical and social-economic background of the marginalization of minorities using the example of Thailand. Austria: University of Vienna. p. 2017.
Apidechkul T. A 20-year retrospective cohort study of TB infection among the hill tribe HIV/AIDS populations, Thailand. BMC Infectious Disease. 2016;16:72. https://doi.org/10.1186/s12879-016-1407-4.
Apidechkul T, Jiamton S, Jareinpituk S, Kaewkungwal J. Sexual behaviors and HIV infection among pregnant hill tribe women in northern Thailand. Southeast Asian J Trop Med Public Health. 2007;38(6):1061–9.
Apidechkul T, Laingoen O, Suwannaporn S. Inequity in accessing health care service in Thailand in 2015: a case study of the hill tribe people in Mae Fah Luang district, Chiang Rai, Thailand. J Health Res. 2016;30(1):67–71.
Department of Provincial Administration, Ministry of Interior, Thailand. Act on the card 2011. http://www.moi.go.th/portal/page?_pageid=814,1036627,814_1036665&_dad=portal&_schema= PORTAL.
The hill tribe welfare and development center, Chiang Rai province. Hill tribe population. The hill tribe welfare and development center. Chiang Rai: Ministry of Interior; 2016. p. 13–21.
Peter B, Leslie EW, Mark RS, Charles EM. Ethic and sample size. Am J Epidemiol. 2005;161(2):105–10.
Leroi C, Adam P, Khamduang W, Kawilapat S, Neo-Giang-Huong, Ongwandee S, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. In J Infect Dis 2016; 51: 136–43.
Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63.
Centers for Disease Control and Prevention (CDC). Interpretation of hepatitis B serologic test results. 2018. http://www.cdc.gov/hepatitis/hbv/pdfs/serologicchartv8.pdf.
Lana C, Sigrun R, Rania AT. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 2992-2015. Vaccine. 2018;36(1):6–14.
World Health organization (WHO). EPI Fact Sheet: Thailand. http://www.searo.who.int/immunization/data/thailand.pdf
Posuwan N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthakasem R, Vichaiwattana P, Klimfueng S, et al. The success of a universal hepatitis B immunization program as part of Thailand’s EPI after 22 years’ implementation. PLoS One. 2016;11(3):e0150499. https://doi.org/10.1371/journal.pone.0150499.
Ministry of Public Health, Thailand. Efficacy and effectiveness of hepatitis B vaccine among Thai children. https://ddc.moph.go.th/th/site/index
Apidechkul T, Wongnuch P, Sithisarn S, Ruanjai T. Health status of Akha hill tribe in Chiang Rai province, Thailand. J Pub Health Dev. 2016;14(1):77–97.
Scott DP, Inna GO, Gregory AP. The weight of obesity on the human immune response to vaccine. Vaccine. 2015;33(36):4422–9.
Anja S, Beate K. Vaccine responses in newborns. Semin Immunopathol. 2017;39(6):627–42.
Teresa A, Jane B, John RB, Bonnie BB, Wilbur HC, Julian H, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 march 2017. Vaccine. 2018;36(7):921–31.
Pham TT, Le HM, Nguyen DT, Maertens K, Leuridan E, Theeten H, et al. Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Vietnam. Vaccine. 2018;36(38):5760–5.
Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doggany L. Host genetic factors affecting hepatitis B infection outcomes: insights from genome-wide association studies. World J Gastroenterol. 2018;24(30):3347–60.
Angela D, Rebecca H, Aung MN, Mary EG, Moo KP, Joy K, et al. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Infect Dis. 2017;17:552. https://doi.org/10.1186/s12879-017-2660-x.
Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, et al. Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143(2):400–7.
Banks T, Kang J, Watts I, Tyrosvoutis ME, Min AM, Tun NW, et al. High hepatitis B seroprevalence and risk factors for infection in pregnant women on the Thailand-Myanmar border. J Infect Dev Ctries. 2016;10(4):384–8.
Aurpibul L, Kariminia A, Vibol U, Fong MS, Le ON, Hansudewechakul R, et al. Seroprevalence of hepatitis B among HIV-infected children and adolescents receiving antiretroviral therapy in the TREAT Asia pediatric HIV observational database. Pediatr Infect Dis J. 2018;37(8):788–93.
Pichainarong N, Chaveepojnkamjorn W, Luksamijarulkul P, Sujirarat D, Apidechkul T. Hepatitis B carrier among married hill tribe women in northern Thailand. Southeast Asian J Trop Med Public Health. 2003;34(1):114–9.
Apidechkul T. Prevalence and factors associated with type 2diabetes mellitus and hypertension among the hill tribe elderly populations in northern Thailand. BMC Public Health. 2018;18:694. https://doi.org/10.1186/s12889-018-5607-2.
Teerapat U, Tassanee S, Pattama K, Pitchayachuda C, Kamonwan S, Gaidganok S, et al. Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients. Medicine (Baltimore). 2017;96(13):e6554.
Catherine MN, John SL. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014;20(30):10395–404.
Teleban R, Moafi M, Ataei B, Yaran M, Nokhodian Z, Kassaian N, et al. Seroprevalence of hepatitis B infection and associated risk factors among drug users in drop-in centers of Isfahan, Iran. Int J Prev Med. 2018;9(46) DOI: 10.4103.
Demsiss W, Seil A, Fiseha T. Hepatitis B and C: seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia. PLoS One. 2018;13(5):e0196539.
Moradi G, Gouya MM, Azimizan ZF, Mohamadi BA, Darvishi S, Aghasadeghi MR, et al. Prevalence and risk factors for HBV and HCV in prisoners in Iran; a national bio-behavioral surveillance survey in 2015. Tropical Med Int Health. 2018;23(6):641–9.
Drazilova S, Janicko M, Kristian P, Schreter I, Halanova M, Urbancikova I, et al. Prevalence and risk factors of hepatitis B virus infection in Roma and non-Roma people in Slovakia. Int J Environ Res Public Health. 2018;15(5). https://doi.org/10.2290/ijerph15051047.
Amsalu A, Ferede G, Eshetie S, Tadewos A, Assegu D. Prevalence, infectivity, and associated risk factors on hepatitis B virus among pregnant women in Yirgalem hospital, Ethiopia: implication of screening to control mother-to-child transmission. J Pregnancy. 2018:8435910. https://doi.org/10.1155/2018/8435910.
Kapinga D, Aboud S. Seroprevalence and factors associated with hepatitis B virus infection in pregnant women attending antenatal clinic in Karagwe district council, Tanzania. Int J Infect Dis. 2018;73(Supp):369.
Xaydalasouk K, Strobel M, Buisson Y, Black AP, Muller CP. Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factories. PLoS One. 2018;13(7):e0199919.
Linkins RW, Chonwattana W, Holtz TH, Wasinrapee P, Chaikummao S, Varangrat A, et al. Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008. J Med Virol. 2013;85(9):1499–505.
Apidechkul T, Pongwiriyakul S. Factors associated with HIV and HBV co-infection in northern Thailand. Asian Pac J Trop Dis. 2016;6(3):174–8.
Apidechkul T. Epidemiology of the hill tribe HIV/AIDS populations, Thailand. J Med Assoc Thail. 2016;99(6):703–8.
Jobayer M, Chowdhury SS, Shamsuzzaman SM, Islam MS. Prevalence of hepatitis B virus, hepatitis C virus, and HIV in overseas job seekers of Bagladesh with the possible routes of transmission. Mymensigngh Med J. 2016;25(3):530–5.
Bakarey AS, Akinboade IO, Aken’Ova YA. Transmission transmissible hepatitis B virus markers of infection among sickle cell disease patients receiving care at a tertiary health facility in Ibadan, southwest Nigeria. J Immunoassay Immunochem. 2018;39(4):416–27.
Coughlin SS. Recall bias in epidemiological studies. J Cli Epidemiol. 1990;43(1):87–91.
Belbasis L, Bellou V. Introduction to epidemiological studies. Methods Mol Biol. 1793;2018:1–6.